Develop Late-Stage Clinical Cart-Ddbcma In Multiple Myeloma
30/01/2023 14:14
Jan 30 (Reuters) - Arcellx Inc ACLX.O :
* KITE AND ARCELLX CLOSE AGREEMENT TO CO-DEVELOP AND
CO-COMMERCIALIZE LATE-STAGE CLINICAL CART-DDBCMA IN MULTIPLE
MYELOMA
Source text for Eikon: ID:nBw2NCtGVa
Further company coverage: ACLX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Arcellx
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 02:18 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Gilead Extends Tender Offer To Acquire Arcellx
U.S. RESEARCH ROUNDUP-Arcellx, Costar Group, Magnite